THOUSAND OAKS, Calif.--Jan. 15, 2002--Amgen
(Nasdaq:AMGN) today announced that it will report fourth-quarter and
full-year 2001 financial results on Wednesday, January 23, 2002, after
the financial markets close. The announcement will be followed by a
conference call at 1:30 PM (PST) with the investment community,
featuring Kevin Sharer, Chairman and CEO and other members of Amgen´s
Live audio of the conference call will be simultaneously broadcast
over the Internet and will be available to members of the news media,
investors and the general public. The conference call is expected to
last approximately one hour.
This event can be accessed by going to Amgen´s website,
www.amgen.com, and clicking on Investor Center, then on Amgen Events.
The event will be archived and available for replay for 72 hours after
Amgen is a global biotechnology company that discovers, develops,
manufactures and markets cost-effective human therapeutics based on
advances in cellular and molecular biology.
EDITOR´S NOTE: An electronic version of this news release may be
accessed via our web site at www.amgen.com. Visit the Corporate Center
and click on Amgen News. Journalists and media representatives may
sign up to receive all news releases electronically at time of
announcement by filling out a short form in the Amgen News section of
the web site.
|Amgen, Thousand Oaks
|Jeff Richardson, 805/447-3227 (media)
|Cary Rosansky, 805/447-4634 (investors)